Artikkelit - Selaus tekijän mukaan "Vahtera E"
-
Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors; the Finrisk hemostasis study
Salomaa V; Rasi V; Pekkanen J; Vahtera E; Jauhiainen M; Vartiainen E; Ehnholm C; Tuomilehto J; Myllylä G
Arterioscler Thromb Vasc Biol (1995) -
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status
Jousilahti P; Salomaa V; Rasi V; Vahtera E; Palosuo T
J EPIDEMIOL COMMUNITY HEALTH (2003) -
Association of the Fatty Acid Composition of serum Phospholipids With Hemostatic Factors
Salomaa VV; Salminen I; Rasi V; Vahtera E; Aro A; Myllylä G
Arterioscler Thromb Vasc Biol : 5 (1997) -
Haemostatic and other cardiovascular risk factors and socioeconomic status among middle-aged Finnish men and women
Myllykangas M; Pekkanen J; Rasi V; Haukkala A; Vahtera E; Salomaa V
Int J Epidemiol (1995) -
Haemostatic factors and lipoprotein (a) in three geographical areas in Finland: The FINRISKI haemostatic study
Salomaa V; Rasi VP; Vahtera E; Pekkanen J; Pursiainen M; Jauhiainen M; Vartiainen E; Ehnholm C; Myllylä G
J Cardiovasc Risk (1994) -
Haemostatic factors and prevalent coronary heart disease: The FINRISKI haemostatic study
Salomaa V; Rasi V; Pekkanen J; Vahtera E; Jauhiainen M; Vartiainen E; Myllylä G; Ehnholm C
Eur Heart J (1994) -
Hemostatic factors as predictors of coronary events and total mortality. The FINRISK '92 Hemostasis Study
Salomaa V; Rasi V; Kulathinal S; Vahtera E; Jauhiainen M; Ehnholm C; Pekkanen J
Arterioscler Thromb Vasc Biol (2002) -
Hemostatic factors as predictors of stroke and cardiovascular diseases: The FINRISK ’92 Hemostasis Study
Rajecki M; Pajunen P; Jousilahti P; Rasi V; Vahtera E; Salomaa V
BLOOD COAGUL FIBRINOLYSIS (2005) -
Intra- and Interindividual Variability of Hemostatic Factors and Traditional Cardiovascular Risk Factors in a Three-year Follow-up
Salomaa V; Rasi V; Stengård J; Vahtera E; Pekkanen J; Vartiainen E; Ehnholm C; Puska P
Thromb Haemost : 5 (1998) -
Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk
Jousilahti P; Salomaa V; Rasi V; Vahtera E
Atherosclerosis (1999) -
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies
Fibrinogen Studies Collaboration Group; Jackson D; White I; Kostis JB; Wilson AC; Folsom AR; Wu K; Chambless L; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Thompson SG; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi V; Vahtera E; Jousilahti P; DAgostino R; Kannel WB; Wilson PW; Tofler G; Levy D; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Engström G; Berglund G; Loewel H; Koenig W; Hense HW; Meade TW; Cooper JA; De Stavola B; Palosuo T
Stat Med (2009) -
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease - baseline findings of the PAIS project
Jousilahti P; Salomaa V; Rasi V; Vahtera E; Palosuo T
Atherosclerosis (2001) -
The association of sensitive systemic inflammation markers with bronchial asthma
Jousilahti P; Salomaa V; Hakala K; Rasi V; Vahtera E; Palosuo T
ANN ALLERGY ASTHMA IMMUNOL (2002) -
The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity
Salomaa V; Rasi V; Pekkanen J; Jauhiainen M; Vahtera E; Pietinen P; Korhonen HJ; Kuulasmaa K; Ehnholm C
Atherosclerosis (1993) -
Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study
Stengård JH; Salomaa V; Rasi V; Vahtera E; Ehnholm C; Krusius T; Perola M; Vartiainen E
BLOOD COAGUL FIBRINOLYSIS (2001)